Keymed Biosciences’ Kangyueda Approved for CRSwNP Treatment in China
China-based Keymed Biosciences Inc., (HKG: 2162) has announced that it has received another indication approval...
Sichuan Biokin’s GNC-038 Tetra-Specific Antibody Clears for Clinical Trials in Autoimmune Diseases
Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506), a China-based pharmaceutical company, has announced that it...
Changchun High & New Technology Industries Receives FDA Approval for Menopausal VMS Drug Trial
China-based Changchun High & New Technology Industries (Group) Inc., (SHE: 000661) has received the green...
AstraZeneca’s Tagrisso Secures EU Approval for EGFR-Mutated Locally Advanced NSCLC
UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) has announced that the European Commission (EU) has...
Ikena Oncology and Inmagene Biopharmaceuticals to Merge into ImageneBio, Listed on Nasdaq as ‘IMA’
US-based Ikena Oncology, Inc. (NASDAQ: IKNA) and Sino-US biotech Inmagene Biopharmaceuticals have announced their merger...
Sanofi and SK bioscience Broaden Partnership to Develop Next-Gen Pneumococcal Vaccines
French pharmaceutical major Sanofi (NASDAQ: SNY) and South Korea-based SK bioscience (KRX: 302440) have announced...
Corxel Pharmaceuticals Secures Global Rights to CX11, a Novel Oral GLP-1 RA, in Licensing Deal with Vincentage
China-based Corxel Pharmaceuticals (CORXEL) has announced a significant licensing agreement with domestic firm Vincentage, securing...
ETERN Therapeutics’ YAP/TEAD Inhibitor ETS-006 Wins FDA Clinical Approval for Advanced Solid Tumors
China-based biopharmaceutical company ETERN Therapeutics has announced that it has received clinical approval from the...
Bristol-Myers Squibb’s Opdivo-Yervoy Combo Approved by EC for MSI-H/mCRC
Global biopharmaceutical company Bristol-Myers Squibb (BMS, NYSE: BMY) has announced that it has received marketing...
Roche’s Lunsumio Receives NMPA Approval for R/R Follicular Lymphoma Treatment
Swiss pharmaceutical giant Roche (SWX: ROG) has announced that it has received marketing approval from...
BeiGene Rebrands to BeOne Medicines Ltd, Ticker Symbol Changes to “ONC”
China-based BeiGene Ltd, listed on Nasdaq (NASDAQ: BGNE, HKG: 6160, SHA: 688235), has announced a...
RAPT Therapeutics Secures Ex-China Rights to Jemincare Group’s Anti-IgE Antibody JYB1904
US-based biopharmaceutical company RAPT Therapeutics Inc. (NASDAQ: RAPT) has announced that it has obtained the...
Porton Pharma and Dragon Sail Join Forces to Enhance ADC Drug Development
China-based Contract Development and Manufacturing Organization (CDMO) Porton Pharma Solutions has entered into a strategic...
GSK’s Jemperli Combo Shows Improved PFS in Phase III Ovarian Cancer Trial
UK-based GSK plc (NYSE: GSK) has announced a positive readout from the Phase III FIRST-ENGOT-OV44...
Pfizer’s Braftovi Receives FDA Approval for Metastatic Colorectal Cancer Treatment
US-based Pfizer (NYSE: PFE) has announced receiving an indication extension approval from the US Food...
Eli Lilly’s Zepbound Receives FDA Approval for Moderate-to-Severe OSA and Obesity
US pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has revealed that the US Food...
Novo Nordisk’s Alhemo Receives FDA Approval for Hemophilia A and B Prophylaxis
Denmark-based Novo Nordisk A/S (NYSE: NVO) has announced that the US Food and Drug Administration...
Boehringer Ingelheim-SEC Joint Incubator Launches in Shenzhen’s Luohu District
On December 23, the Boehringer Ingelheim-SEC Joint innovative incubator was inaugurated in Luohu District, Shenzhen....
CStone Pharmaceuticals Initiates First-in-Human Trial for PD-1/VEGF/CTLA-4 Trispecific Antibody CS2009
China-based CStone Pharmaceuticals (HKG: 2616) has announced the clinical filing for its CS2009, a PD-1/VEGF/CTLA-4...
Becton, Dickinson and Co. Launches RMB1.332 Billion Factory in Jiangsu for Pre-Filled Syringes
US-based Becton, Dickinson and Co., (BD) has officially put into operation its new factory in...